No specific risk factors for clots with AstraZeneca Covid-19 jab: Europe health regulator, SE Asia News & Top Stories – The Straits Times

SINGAPORE (BLOOMBERG, REUTERS, AGENCE FRANCE-PRESSE) – The AstraZeneca Covid-19 vaccine came under the spotlight following reports of rare blood clots, some of them fatal, among some adult vaccine recipients. Concerns about the vaccine centred on an unusual type of blood clot in the brain called cerebral venous sinus thrombosis (CVST). There were also some cases of clots in the abdomen and in the arteries, which occurred together with low levels of blood platelets. The European Medicines Agency said it had reports of 169 cases of the rare clotting disorder out of 34 million doses administered within Europe, roughly one for…